|
π
|
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
16 auth.
C. Dinardo,
K. Pratz,
V. Pullarkat,
B. Jonas,
M. Arellano,
P. Becker,
O. Frankfurt,
M. Konopleva,
A. Wei,
H. Kantarjian,
...
T. Xu,
W. Hong,
B. Chyla,
J. Potluri,
D. Pollyea,
A. Letai
|
10 |
2019 |
10
π
|
|
π
|
Durable Remissions with Ivosidenib in IDH1βMutated Relapsed or Refractory AML
40 auth.
C. Dinardo,
E. Stein,
S. de Botton,
G. Roboz,
J. Altman,
A. Mims,
R. Swords,
R. Collins,
G. Mannis,
D. Pollyea,
W. Donnellan,
A. Fathi,
A. Pigneux,
H. Erba,
G. Prince,
...
A. Stein,
G. Uy,
J. Foran,
E. Traer,
R. Stuart,
M. Arellano,
J. Slack,
M. Sekeres,
C. Willekens,
S. Choe,
Hongfang Wang,
V. Zhang,
K. Yen,
S. Kapsalis,
Hua Yang,
D. Dai,
Bin Fan,
M. Goldwasser,
Hua Liu,
S. Agresta,
Bin Wu,
E. Attar,
M. Tallman,
R. Stone,
H. Kantarjian
|
10 |
2018 |
10
π
|
|
π
|
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
19 auth.
C. Dinardo,
K. Pratz,
A. Letai,
B. Jonas,
A. Wei,
M. Thirman,
M. Arellano,
M. Frattini,
H. Kantarjian,
R. Popovic,
...
B. Chyla,
T. Xu,
M. Dunbar,
S. Agarwal,
R. Humerickhouse,
M. Mabry,
J. Potluri,
M. Konopleva,
D. Pollyea
|
9 |
2018 |
9
π
|
|
π
|
Salivary Proteomics for Oral Cancer Biomarker Discovery
10 auth.
Shen Hu,
M. Arellano,
P. Boontheung,
Jianghuai Wang,
Hui Zhou,
Jiang Jiang,
...
D. Elashoff,
R. Wei,
J. Loo,
D. Wong
|
8 |
2008 |
8
π
|
|
π
|
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
31 auth.
B. Shah,
A. Ghobadi,
O. Oluwole,
A. Logan,
N. Boissel,
R. Cassaday,
T. Leguay,
M. Bishop,
M. Topp,
D. Tzachanis,
K. O'Dwyer,
M. Arellano,
Yi Lin,
M. Baer,
G. Schiller,
...
Jae H. Park,
M. Subklewe,
M. Abedi,
M. Minnema,
W. Wierda,
D. DeAngelo,
P. Stiff,
D. Jeyakumar,
C. Feng,
Jinghui Dong,
T. Shen,
Francesca Milletti,
J. Rossi,
R. Vezan,
B. K. Masouleh,
R. Houot
|
8 |
2021 |
8
π
|
|
π
|
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
32 auth.
T. Hitosugi,
Lu Zhou,
Shannon E Elf,
Jun Fan,
Hee-Bum Kang,
J. Seo,
Changliang Shan,
Qing Dai,
Liang Zhang,
Jianxin Xie,
T. Gu,
P. Jin,
M. AleΔkoviΔ,
G. Leroy,
Yibin Kang,
...
J. Sudderth,
R. Deberardinis,
C. Luan,
G. Chen,
S. Muller,
D. Shin,
T. Owonikoko,
S. Lonial,
M. Arellano,
H. Khoury,
F. Khuri,
Benjamin H. Lee,
K. Ye,
T. Boggon,
Sumin Kang,
Chuan He,
J. Chen
|
8 |
2012 |
8
π
|
|
π
|
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
31 auth.
G. Roboz,
C. Dinardo,
E. Stein,
S. de Botton,
A. Mims,
G. Prince,
J. Altman,
M. Arellano,
W. Donnellan,
H. Erba,
G. Mannis,
D. Pollyea,
A. Stein,
G. Uy,
J. Watts,
...
A. Fathi,
H. Kantarjian,
M. Tallman,
S. Choe,
D. Dai,
Bin Fan,
Hongfang Wang,
V. Zhang,
K. Yen,
S. Kapsalis,
D. Hickman,
Hua Liu,
S. Agresta,
Bin Wu,
E. Attar,
R. Stone
|
8 |
2019 |
8
π
|
|
π
|
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.
21 auth.
Lingtao Jin,
D. Li,
Gina N. Alesi,
Jun Fan,
Hee-Bum Kang,
Zhouzhou Lu,
T. Boggon,
P. Jin,
H. Yi,
Elizabeth R Wright,
...
D. Duong,
Nicholas T. Seyfried,
Robert A. Egnatchik,
R. Deberardinis,
K. Magliocca,
Chuan He,
M. Arellano,
H. Khoury,
D. Shin,
F. Khuri,
Sumin Kang
|
8 |
2015 |
8
π
|
|
π
|
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
28 auth.
Jun Fan,
Changliang Shan,
Hee-Bum Kang,
Shannon E Elf,
Jianxin Xie,
M. Tucker,
T. Gu,
M. Aguiar,
S. Lonning,
Huaibin Chen,
M. Mohammadi,
Laura-Mae P. Britton,
B. Garcia,
M. AleΔkoviΔ,
Yibin Kang,
...
Ε . Kaluz,
N. Devi,
Erwin G. Van Meir,
T. Hitosugi,
J. Seo,
S. Lonial,
M. Gaddh,
M. Arellano,
H. Khoury,
F. Khuri,
T. Boggon,
Sumin Kang,
J. Chen
|
8 |
2014 |
8
π
|
|
π
|
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia.
48 auth.
G. Uy,
Ibrahim Aldoss,
M. Foster,
P. Sayre,
M. Wieduwilt,
A. Advani,
J. Godwin,
M. Arellano,
K. Sweet,
A. Emadi,
F. Ravandi,
H. Erba,
M. Byrne,
L. Michaelis,
M. Topp,
...
N. Vey,
F. Ciceri,
M. Carrabba,
S. Paolini,
G. Huls,
M. JongenβLavrencic,
M. Wermke,
P. Chevallier,
E. Gyan,
C. RΓ©cher,
P. Stiff,
K. Pettit,
B. LΓΆwenberg,
S. Church,
Erica Anderson,
J. Vadakekolathu,
Marianne T Santaguida,
M. Rettig,
J. Muth,
Teia Curtis,
Erin Fehr,
Kuo Guo,
Jian Zhao,
Ouiam Bakkacha,
K. Jacobs,
K. Tran,
P. Kaminker,
M. Kostova,
E. Bonvini,
R. Walter,
J. Davidson-Moncada,
S. Rutella,
J. Dipersio
|
7 |
2020 |
7
π
|
|
π
|
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
24 auth.
G. Issa,
Ibrahim Aldoss,
J. Dipersio,
Branko Cuglievan,
R. Stone,
M. Arellano,
M. Thirman,
M. Patel,
David S. Dickens,
S. Shenoy,
...
N. Shukla,
H. Kantarjian,
S. Armstrong,
F. Perner,
J. Perry,
G. Rosen,
R. Bagley,
M. Meyers,
P. Ordentlich,
Yu Gu,
Vinit Kumar,
Steven Smith,
G. McGeehan,
E. Stein
|
7 |
2023 |
7
π
|
|
π
|
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
11 auth.
W. Stock,
D. Douer,
D. DeAngelo,
M. Arellano,
A. Advani,
L. Damon,
...
T. Kovacsovics,
M. Litzow,
M. Rytting,
G. Borthakur,
A. Bleyer
|
7 |
2011 |
7
π
|
